Brightspring Health Services Inc

Brightspring Health Services Inc (BTSG) Stock Analysis

$59.130

-1.721 (-2.91%)At close

Loading chart…
High
61.310
Open
60.540
VWAP
59.83
Vol
1.51M
Mkt Cap
Low
59.040
Amount
90.12M
EV/EBITDA, TTM
18.10

BrightSpring Health Services, Inc. provides complementary home and community-based pharmacy and provides health solutions for complex populations in need of specialized and/or chronic care. Through the Company's service lines, including pharmacy, home health care and rehab care, it provides comprehensive and more integrated care and clinical solutions in all 50 states to customers, clients and patients. Its services are organized and managed through two reportable segments: Pharmacy Solutions and Provider Services. The Pharmacy Solutions segment operates long-term institutional pharmacies, hospice pharmacies, specialty oncology pharmacies, and home infusion centers. It provides infused, injectable, and oral medication services in the home and clinic. The Provider Services segment provides a variety of services to help manage the whole-person health of its patients in their homes and communities through services such as home health care and hospice care and long-term specialty care.

AI analysis of Brightspring Health Services Inc (BTSG)

buy

Brightspring Health Services Inc is a good buy right now due to its strong revenue growth and positive analyst sentiment. The current price of $59.13 is below the average analyst price target of $78.75, indicating significant upside potential. Additionally, the company has shown a remarkable year-to-date change of +53.98% and a one-year change of +147.61%, reflecting strong market performance. However, the RSI is currently at 44.194, suggesting that the stock is not overbought, which could provide a favorable entry point for long-term investors. The main risk is the recent volatility, as evidenced by a 17.5% drop following strong earnings, indicating potential market sensitivity to performance metrics.

Valuation Metrics

The current forward P/E ratio for Brightspring Health Services Inc (BTSG) is 33.44, compared to its 5-year average forward P/E of 27.32.

Forward P/E

Fair
5Y Average P/E
27.32
Current P/E
33.44
Overvalued
35.79
Undervalued
18.84

Forward EV/EBITDA

Overvalued
5Y Average EV/EBITDA
12.63
Current EV/EBITDA
18.10
Overvalued
16.63
Undervalued
8.62

Forward P/S

Overvalued
5Y Average P/S
0.36
Current P/S
0.67
Overvalued
0.54
Undervalued
0.18

Alphio AI Price Scenarios for BTSG

Scenario prices are the last monthly forecast band of the current year. Probabilities are fixed model weights (25 / 50 / 25), not guarantees.

B

Bull

Bull · 25%BTSG

$28.42

Scenario price

B

Base

Base · 50%BTSG

$25.10

Scenario price

B

Bear

Bear · 25%BTSG

$20.54

Scenario price

Whales holding BTSG

I

Integral Health Asset Management, LLC

+ HoldingBTSG

+15.08%

3M Return

C

Caledonia (Private) Investments Pty Limited

+ HoldingBTSG

+0.49%

3M Return

A

Applied Finance Advisors, LLC

+ HoldingBTSG

-5.76%

3M Return

S

Seven Grand Managers LLC

+ HoldingBTSG

-6.64%

3M Return

K

Kohlberg & Company, L.L.C.

+ HoldingBTSG

-12.01%

3M Return

BTSG FAQ — answered by Alphio AI

BrightSpring Health Services, Inc. provides complementary home and community-based pharmacy and provides health solutions for complex populations in need of specialized and/or chronic care. Through the Company's service lines, including pharmacy, home health care and rehab care, it provides comprehensive and more integrated care and clinical solutions in all 50 states to customers, clients and patients. Its services are organized and managed through two reportable segments: Pharmacy Solutions and Provider Services. The Pharmacy Solutions segment operates long-term institutional pharmacies, hospice pharmacies, specialty oncology pharmacies, and home infusion centers. It provides infused, injectable, and oral medication services in the home and clinic. The Provider Services segment provides a variety of services to help manage the whole-person health of its patients in their homes and communities through services such as home health care and hospice care and long-term specialty care. It operates in the Healthcare sector (HOME HEALTH CARE SERVICES industry).

Brightspring Health Services Inc is a good buy right now due to its strong revenue growth and positive analyst sentiment. The current price of $59.13 is below the average analyst price target of $78.75, indicating significant upside potential. Additionally, the company has shown a remarkable year-to-date change of +53.98% and a one-year change of +147.61%, reflecting strong market performance. However, the RSI is currently at 44.194, suggesting that the stock is not overbought, which could provide a favorable entry point for long-term investors. The main risk is the recent volatility, as evidenced by a 17.5% drop following strong earnings, indicating potential market sensitivity to performance metrics.

This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.

Get Started